Regorafenib

#	Item
1	INTEGRATE: A phase 2 study of regorafenib in advanced oesophagogastric cancer The INTEGRATE trial is helping answer an important health question. It has provided evidence that a new treatment, regorafenib, acts against t Add to Reading List Source URL: www.ctc.usyd.edu.au - Date: 2016-07-12 00:35:29
2	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STIVARGA safely and effectively. See full prescribing information for STIVARGA.  Dermatological toxicity: Interr Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2015-04-14 15:23:06 RTT Nonsteroidal anti-inflammatory drugs Pyridines Regorafenib Ureas Adverse effect Ibuprofen Anakinra Tofacitinib
3	NATIONAL CANCER DRUG FUND PRIORITISATION SCORES Drug Indication REGORAFENIB Add to Reading List Source URL: www.england.nhs.uk Language: English - Date: 2013-10-02 06:24:46 End point of clinical trials Quality of life Progression-free survival Medical terms Medicine Health
4	NATIONAL CANCER DRUG FUND PRIORITISATION SCORES Drug Indication REGORAFENIB Add to Reading List Source URL: www.england.nhs.uk Language: English - Date: 2013-10-02 06:24:55 Organofluorides Pfizer Pyrroles Sunitinib Health Quality of life End point of clinical trials Progression-free survival Medical terms Medicine Indoles